Google already controls search, they are quickly gaining market share to control the browser, and when you put in DNS, it becomes the trifecta of complete navigational control.
FORBES: A Closer Look at Google Public DNS
2.
Now Aranesp controls 26% of the U.S. anemia market versus 38% for Procrit and is gaining share, according to IMS Health.